A Common Variant in the FTO Gene Is Associated with Body Mass Index and Predisposes to Childhood and Adult Obesity

Obesity is a serious international health problem that increases the risk of several common diseases. The genetic factors predisposing to obesity are poorly understood. A genome-wide search for type 2 diabetes–susceptibility genes identified a common variant in the FTO (fat mass and obesity associated) gene that predisposes to diabetes through an effect on body mass index (BMI). An additive association of the variant with BMI was replicated in 13 cohorts with 38,759 participants. The 16% of adults who are homozygous for the risk allele weighed about 3 kilograms more and had 1.67-fold increased odds of obesity when compared with those not inheriting a risk allele. This association was observed from age 7 years upward and reflects a specific increase in fat mass.

[1]  K. Clément,et al.  GAD2 on Chromosome 10p12 Is a Candidate Gene for Human Obesity , 2003, PLoS biology.

[2]  Warszawski Uniwersytet Medyczny,et al.  Diabetes care , 2019, Health at a Glance.

[3]  A. Mccarthy.  Development , 1996, Current Opinion in Neurobiology.

[4]  M. McCarthy,et al.  Significant Linkage of BMI to Chromosome 10p in the U.K. Population and Evaluation of GAD2 as a Positional Candidate , 2006, Diabetes.

[5]  宁北芳,et al.  疟原虫var基因转换速率变化导致抗原变异[英]／Paul H, Robert P, Christodoulou Z, et al//Proc Natl Acad Sci U S A , 2005 .

[6]  M. Mattéi,et al.  Programmed cell death is affected in the novel mouse mutant Fused toes (Ft). , 1994, Development.

[7]  M. Neale,et al.  Genetic and Environmental Factors in Relative Body Weight and Human Adiposity , 1997, Behavior genetics.

[8]  K. Flegal,et al.  Prevalence of overweight and obesity in the United States, 1999-2004. , 2006, JAMA.

[9]  M. Gerretsen,et al.  A phase III randomised trial of cisplatinum, methotrextate, cisplatinum + methotrexate and cisplatinum + 5-FU in end stage squamous carcinoma of the head and neck. Liverpool Head and Neck Oncology Group. , 1990, British Journal of Cancer.

[10]  M. McCarthy,et al.  No Evidence of Association of ENPP1 Variants With Type 2 Diabetes or Obesity in a Study of 8,089 U.K. Caucasians , 2006, Diabetes.

[11]  R. Rosenfeld.  Nature , 2009, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

[12]  徐晶（译）.  基因科学与亲子鉴定——国际流行病与公众健康杂志J Epidemiol Community Health , 2005 .

[13]  D. Reich,et al.  Principal components analysis corrects for stratification in genome-wide association studies , 2006, Nature Genetics.

[14]  Xiaofeng Zhu,et al.  On a semiparametric test to detect associations between quantitative traits and candidate genes using unrelated individuals , 2003, Genetic epidemiology.

[15]  S. O’Rahilly,et al.  Genetics of obesity in humans. , 2006, Endocrine reviews.

[16]  D. Altman,et al.  Measuring inconsistency in meta-analyses , 2003, BMJ : British Medical Journal.

[17]  R. Dildrop,et al.  The mouse Fused toes (Ft) mutation is the result of a 1.6-Mb deletion including the entire Iroquois B gene cluster , 2002, Mammalian Genome.

[18]  F. Hu,et al.  A Common Genetic Variant Is Associated with Adult and Childhood Obesity , 2006, Science.

[19]  K. Clément,et al.  Variants of ENPP1 are associated with childhood and adult obesity and increase the risk of glucose intolerance and type 2 diabetes , 2005, Nature Genetics.

[20]  R. Uauy,et al.  Obesity in children and young people: a crisis in public health. , 2004, Obesity reviews : an official journal of the International Association for the Study of Obesity.